Home › Chronic Pain › NCT06515925
Our Whole Lives Gemini: Virtual Integrative Medical Group Visits for Managing Chronic Pain
Phase II: GEMINI: Virtual Integrative Medical Group Visits for Managing Chronic Pain
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * English-speaking adults * Over the age of 18 * Experiencing chronic musculoskeletal pain. (Pain may have more than one source; Pain must be non-malignant; Participant must have an average pain intensity of ≥ 4 (1 out of 10) in the past 7 days; Participant must meet the chronic criteria of a pain problem that has persisted at least 3 months, and has resulted in pain on at least half the days in the past 6 months) Exclusion Criteria: * Inability to understand English at a level necessary for informed consent and understanding participation instructions, and participating in the group; * Serious underlying systemic or co-morbid conditions or life event that precludes physical or cognitive ability to participate in the study. * Severe depression * Current mania or psychosis; * Active heroin or cocaine use in the past 3 months * Heavy alcohol use * Known or planned pregnancy
About the study
The goal of this research study is to test the efficacy of a non-prescription medicine, web-based platform solution for patients with chronic pain, to improve pain self-management and related outcomes. The main question investigators aim to answer is; would the use of this web-based intervention plus an online group visit compared to control result in better pain-related outcomes and improved pain impact?
What is being tested
- Our Whole Lives (OWL) (behavioral)
- Low Dose Mindfulness Training (behavioral)
Sponsor: Cambridge Health Alliance · Participants: 212 · Started: Aug 1, 2024
Contact the study team
- Paula Gardiner · Phone: 617 806 8735
- Alexandra Comeau · Phone: 617-806-8735
Official record on ClinicalTrials.gov — NCT06515925
Locations in the U.S.
| Massachusetts | Cambridge Health Alliance Center for Mindfulness and Compassion, Malden |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.